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Summary
There is a growing body of evidence supporting the roles
of small, dense LDL and plasma triglyceride (TG), both
features of the atherogenic lipoprotein phenotype, as risk
factors for coronary heart disease. Although family stud-
ies and twin studies have demonstrated genetic influ-
ences on these risk factors, the specific genes involved
remain to be determined definitively. The purpose of this
study was to investigate genetic linkage between LDL
size, TG, and related atherogenic lipoproteins and can-
didate genes known to be involved in lipid metabolism.
The linkage analysis was based on a sample of 126 DZ
women twin pairs, which avoids the potentially con-
founding effects of both age and gender, by use of a
quantitative sib-pair linkage-analysis approach. Eight
candidate genes were examined, including those for mi-
crosomal TG-transfer protein (MTP), hepatic lipase,
hormone-sensitive lipase, apolipoprotein (apo) B, apo
CIII, apo E, insulin receptor, and LDL receptor. The
analysis suggested genetic linkage between markers for
the apo B gene and LDL size, plasma levels of TG, of
HDL cholesterol, and of apo B, all features of the ath-
erogenic lipoprotein phenotype. Furthermore, evidence
for linkage was maintained when the analysis was lim-
ited to women with a major LDL-subclass diameter
1255 A˚, indicating that the apo B gene may influence
LDL heterogeneity in the intermediate-to-large size
range. In addition, linkage was found between the MTP
gene and TG, among all the women. These findings add
to the growing evidence for genetic influences on the
atherogenic lipoprotein phenotype and its role in genetic
susceptibility to atherosclerosis.
Received June 9, 1997; accepted for publicationDecember 15, 1997;
electronically published February 6, 1998.
Address for correspondence and reprints: Dr. Melissa A. Austin,
Department of Epidemiology, Box 357236, University of Washington,
Seattle, WA 98195. E-mail: maustin@u.washington.edu
 1998 by The American Society of Human Genetics. All rights reserved.
0002-9297/98/6202-0027$02.00
Introduction
The importance of elevated plasma LDL cholesterol as
a risk factor for coronary heart disease (CHD) is indis-
putable, especially in light of evidence from intervention
trials such as the 4S study (Scandinavian Simvastatin
Survival Study Group 1994) and the West of Scotland
study (Shepherd et al. 1995). There also is a growing
body of evidence to support the roles of LDL hetero-
geneity and, in particular, small, dense LDL in the risk
of CHD. Beginning in the early 1980s, at least nine case/
control studies demonstrated that a predominance of
small, dense LDL particles is more common in cases than
in controls (reviewed in Austin et al. 1994), with relative
risks (RRs) ranging from 3.0 (Austin et al. 1988a) to
6.9 (Griffin et al. 1994).
Most recently, the results of nested case/control anal-
yses from the Stanford Five City Project, the Physicians’
Health Study, and the Quebec Cardiovascular Study
have provided the first prospective data evaluating LDL
size as a risk factor (Gardner et al. 1996; Stampfer et
al. 1996; Lamarche et al. 1997). The Stanford study was
based on fatal and nonfatal incident cases of CHD and
found a highly significant case/control mean difference
in LDL size (5.1 A˚; ), demonstrating thatP ! .001
smaller LDL size predicted incident CHD in this pop-
ulation (Gardner et al. 1996). In the Physicians’ Health
Study, baseline LDL-diameter values were smaller for
cases, compared with those for matched controls (256
A˚ vs. 259 A˚, respectively; ), and the RR wasP ! .001
1.38 (95% confidence interval [CI] of 1.18–1.62) for an
8-A˚ decrease in LDL size (Stampfer et al. 1996). Finally,
the results of the Quebec Cardiovascular Study reported
an RR of 3.6 ( ) for the lowest tertile of LDL size,P ! .01
when incident cases and matched controls were com-
pared. Taken together, these data demonstrate that
small, dense LDL is a predictor of CHD, at least in these
samples of middle-aged Caucasian individuals.
These studies have led to numerous investigations of
the possible biological mechanisms underlying the ob-
served epidemiological associations. Although the met-
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abolic mechanisms are still being investigated, at least
four explanations of this relationship have been pro-
posed: (1) the association of small, dense LDLwith other
atherogenic lipoproteins, including increased plasma tri-
glyceride (TG) and decreased HDL cholesterol (Austin
et al. 1990b); (2) increased oxidative susceptibility of
small, dense LDL particles (reviewed in Austin et al.
1994); (3) lower affinity for the LDL receptor (LDL-R),
owing to alterations in apolipoprotein (apo) B config-
uration (Galeano et al. 1994); and/or (4) the presence
of insulin-resistance syndrome in subjects with small,
dense LDL (Selby et al. 1993). Thus, the small, dense
LDL phenotype may confer atherosclerosis susceptibil-
ity, through multiple mechanisms that in fact may be
synergistic (Austin and Krauss 1995).
Many studies, including several of those noted above,
have demonstrated associations between small, dense
LDL and plasma concentrations of other lipids and lipo-
proteins, leading to the designation of small, dense LDL
as an “atherogenic lipoprotein phenotype” (Austin et al.
1990b). The strongest association is an inverse relation-
ship between LDL size and TG, although small, dense
LDL is also simultaneously associated with increased
apo B plasma levels and decreased HDL cholesterol and
apo AI. The cross-sectional TG association has been con-
firmed in a sample of Mexican Americans (Haffner et
al. 1993) and in a longitudinal study based on the Fra-
mingham Offspring Study (McNamara et al. 1992).
Although the role of TG as a risk factor has been
controversial for 13 decades (Austin 1991; NIH 1993),
accumulating epidemiological evidence is now demon-
strating that elevated TG is indeed associated with in-
creased risk of cardiovascular disease (CVD). For ex-
ample, we recently performed a meta-analysis of results
from all population-based prospective studies of TG and
CVD that are available from the literature, to determine
whether TG is a risk factor for CVD, independent of
HDL cholesterol (Hokanson and Austin 1996). The
analysis included 17 studies, 16 that studied men and 5
that studied women, including a total of 46,413 men
and 10,864 women. Application of meta-analysis ap-
proaches resulted in a weighted, summary RR (stan-
dardized for a 1 mmol/l or 88 mg/dl increase in plasma
TG) of 1.32 (95% CI of 1.26–1.39) for men and 1.76
(95% CI of 1.50–2.07) for women, both of which are
statistically highly significant. Of the 6 studies that re-
ported RRs adjusted for HDL cholesterol, the RRs for
TG were 1.14 (95% CI of 1.05–1.28) for men and 1.37
(95% CI of 1.13–1.66) for women. Although lower,
these values are still statistically significant and confirm
that TG is a risk factor for CVD, independent of HDL
cholesterol.
Several studies have demonstrated genetic influences
on both LDL size and TG levels, possibly reflecting ge-
netic susceptibility to atherosclerosis. On the basis of
complex segregation analysis and gradient-gel electro-
phoresis results, genetic analyses in the United States
have found major-gene effects on LDL subclass phe-
notypes and/or on LDL size, in primarily healthy families
and in families with familial combined hyperlipidemia
(FCHL) (Austin et al. 1988b, 1990a, 1993a). These sin-
gle-gene results have been confirmed on the basis of two
different samples, of healthy families and families with
FCHL, from the Netherlands, by use of a density-gra-
dient ultracentrifugation approach to characterization of
LDL heterogeneity (de Graaf et al. 1992; Bredie et al.
1996). Importantly, each of these studies found that the
expression of the small, dense LDL trait differed by age
and gender and by the hormonal status in women. In
combination with data from twin studies of both men
and women (Lamon-Fava et al. 1991; Austin et al.
1993b), these data provide strong evidence that LDL
heterogeneity is genetically influenced.
Another recent complex segregation analysis (Cullen
et al. 1994) investigated the inheritance of TG levels in
families with FCHL, including families studied in Seattle
in the early 1970s (Goldstein et al. 1973) and a sample
of families newly recruited through probands ascer-
tained at the Northwick Park Hospital. In both sets of
families, a single major-gene effect was seen for TG levels
but not for total cholesterol. In the Northwick Park fam-
ilies, a recessive mode of inheritance was found, with a
common allele frequency ( ) for the proposedq  .25
high-TG allele. Although a recessive model also was
found for the Seattle families, the estimated allele fre-
quency ( ) was lower, and a multifactorial inher-q  .05
itance component also was identified. Thus, these anal-
yses provide evidence for strong major-gene effects on
TG levels, at least in FCHL families.
However, the gene(s) controlling LDL size, TG, and
related atherogenic lipoproteins remains to be estab-
lished definitively. In this study, we use a candidate-gene
approach to search for linkage to the characteristic lip-
oproteins of the atherogenic lipoprotein phenotype,
building on previous studies that also used this strategy.
Two such studies provided evidence against linkage to
the apo B gene on chromosome 2 (Austin et al. 1991;
LaBelle et al. 1991), whereas two other studies reported
linkage with the LDL-receptor (LDL-R) gene, the apo
CIII gene, the cholesterol ester–transfer protein (CETP)
gene, and the superoxide dismutase (MnSOD) gene
(Nishina et al. 1992; Rotter et al. 1996).
The candidate-gene approach has identified a number
of genes involved in dyslipidemia and in the risk of cor-
onary artery disease (CAD). The apo B gene is of par-
ticular interest, since several polymorphic sites in this
gene have been associated with differences in plasma
cholesterol and TG levels and demonstrate gene/diet in-
teractions (Humphries et al. 1995). Variation at several
other genetic loci, including the apo CIII gene locus, has
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been consistently associated with differences in plasma
TG levels (Humphries et al. 1996). Furthermore, vari-
ation at the apo AI locus (Talmud et al. 1994) is asso-
ciated with differences in apo AI levels and shows ge-
notype/smoking interactions. Although there are no
reports on the association of variation in the microsomal
TG-transfer protein (MTP) gene and altered lipid levels,
Narcisi et al. (1995) have reported four polymorphic
amino acid changes within the amino terminal domain
of the MTP gene, suggesting that these polymorphisms
may influence plasma lipid levels. Shimada et al. (1996)
reported the presence of an R309C variant in the hor-
mone-sensitive lipase (HSL) gene, associated with dif-
ferences in cholesterol levels, in a Japanese population
study. The highly polymorphic dinucleotide repeats in
both intron 10 of the MTP gene (Sharp et al. 1994) and
intron 7 of the HSL gene (Levitt et al. 1992) are ideal
for sib-pair studies.
The purpose of this study was to determine if there
is genetic linkage between LDL size, TG, and/or related
atherogenic lipoproteins and candidate genes known to
be involved in lipid metabolism. The linkage analysis
was based on a large, unique sample of DZ women twin
pairs, which avoids the potentially confounding effects
of both age and gender, by use of quantitative sib-pair
linkage analysis.
Subjects and Methods
Subjects
Study subjects were participants in the second ex-
amination of the Kaiser Permanente Women Twins
Study in Oakland, California. Examination 2 was con-
ducted between 1989 and 1990 and included 704 in-
dividuals, representing 81% of the original cohort, ex-
amined between 1979 and 1980 (Austin et al. 1987;
Selby et al. 1993). This sample included 206 MZ and
146 DZ twin pairs. The study was approved by the
Kaiser Permanente Institutional Review Board, and each
woman provided written informed consent for partici-
pation in examination 2.
At the time of examination 2, each woman completed
a health-history questionnaire and a physical examina-
tion, including anthropometric and laboratory measure-
ments. The average age at examination 2 was 51 years,
and the majority (90%) of women in the sample were
white. DZ twin pairs who participated in examination
2 were eligible for the present analysis, with zygosity
having been previously determined at examination 1 on
the basis of 20 polymorphic loci, such that the proba-
bility of misclassification, as MZ, of a pair that was
concordant for all these markers was !.001 (Austin et
al. 1987).
Laboratory Methods
Lipids, lipoproteins, and apo B.—After the women had
completed an overnight fast, 30 ml of whole blood was
collected into EDTA-containing tubes. Plasma was sep-
arated by centrifugation within 2 h and was stored under
refrigeration. Nondenaturing gradient-gel electropho-
resis was performed on the plasma by use of 2%–16%
polyacrylamide gradient gels (Pharmacia), as described
elsewhere (Krauss and Burke 1982; Nichols et al. 1986).
The estimated diameter of the major LDL subclass was
calculated on the basis of a calibration curve constructed
from high-molecular-weight standards run on the same
gel (Krauss and Burke 1982). The diameter denoted
“LDL peak-particle diameter” (LDL-PPD), or “LDL
size,” is a continuous variable and is used in this analysis
as a measure of LDL heterogeneity.
Total HDL cholesterol (Warnick et al. 1985) and TG
(Nagele et al. 1984) were determined, by standardized
methods, at the Donner Laboratory (Lawrence Berkeley
National Laboratory) (R. M. Krauss, unpublished data),
a participating laboratory in the Centers for Disease
Control lipid-standardization program. LDL cholesterol
was determined by use of the Friedewald formula (Frie-
dewald et al. 1972), when TG values were !400 mg/dl.
(Women with TG values x400 mg/dl were excluded
from the analysis [see Statistical Genetic Analysis
section].)
Apo B plasma levels were initially measured by max-
imal single-radial immunodiffusion (RID) assay (Ouch-
erony and Nilsson 1978), by use of commercially avail-
able plates and reagents (Tago), for 172 of the 291
available samples from the DZ twins. Calibration stan-
dards were validated by Northwest Lipid Research
Clinic, and in-house control plasma was used to monitor
variation of the measurement from plate to plate (co-
efficient of variation [CV] 10%). This method was
then replaced by a more efficient immunoturbidimetric
assay (ITA) method, for the remaining 119 samples (Ri-
fai and King 1986; Smith et al. 1987). Reagents, stan-
dards, and reference plasma controls—with and without
elevated lipids—are included in the ITA reagent kit (Bac-
ton Assay Systems). Measurements were performed in
accordance with the kit instructions, by use of a Corning
Express 550 analyzer (Ciba). These measurements are
Clinical Laboratory Improvements Amendments-li-
censed procedures, which are validated twice yearly by
College of American Pathologists-test validation. Ref-
erence controls supplied with the kit and in-house
plasma controls were used to monitor interrun varia-
bility (CV 7.5%). Although these two methods were
highly correlated ( , on the basis of 66 twin sam-r  .73
ples, by use of both methods), the immunoturbidimetric
values were adjusted by linear regression to RID values,
and these were used in the present analysis.
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Table 1
Candidate-Gene Polymorphisms Typed for Women Twins
Candidate Gene Chromosome Marker No. of Alleles Heterozygosity Indexa Reference
Apo E 19 Triallelic: iso-
forms E2, E3,
and E4
3 .43 Bolla et al. (1995)
Apo B 2 VNTR at 3′ end 14 .74 Boerwinkle et al. (1989)
Tetranucleotide
repeat in in-
tron 20
6 .60 Zuliani and Hobbs (1990a)
MTP 4 CA repeat in
intron 10
13 .74 Sharp et al. (1994)
Apo CIII 11 Tetranucleotide
repeat in in-
tron 3
7 .60 Zuliani and Hobbs
(1990b)
HL 15 CA repeat in
intron 8
7 .63 Bhattacharya et al. (1991)
HSL 19 GT repeat in
intron 7
14 .67 Levitt et al. (1992)
IR 19 CT repeat in
intron 2
12 .51 Xiang et al. (1991)
LDL-R 19 D19S394, 250
kb 5′ to LRL-
R gene
21 .91 Day et al. (1997)
a Based individually on all women in the study.
DNA extraction.—By use of the same blood samples
described above, white and red blood cells were retained
after centrifugation and removal of plasma. These sam-
ples were frozen at 70C until 1995. At that time, the
samples were transferred from Kaiser Permanente, in
Oakland, to the Donner Laboratory, in Berkeley, for
isolation of DNA. DNAwas extracted fromwhole blood
by use of a NH4Cl lysis/salt chloroform method (Mul-
lenbach et al. 1989), modified for DNA isolation from
buffy coats (A. Recinos and Y. Ma, personal commu-
nication). Of the 290 blood samples available from
DZ twins, DNA extraction failed for only 10 (3.5%)
samples.
DNA samples were then sent to the Rayne Institute,
University College London, for genotyping in two
batches, one in July 1995 and the other in December
1995. These samples were identified only by anonymous
identification numbers and were blinded for zygosity and
for co-twin status.
Candidate genes.—The eight candidate genes exam-
ined in this analysis and their chromosomal locations
are listed in table 1. These genes included those for apo
E, apo B, MTP, apo CIII, hepatic lipase (HL), HSL, in-
sulin receptor (IR), and LDL-R. Markers were genoty-
ped for each of these candidate genes, by use of the most
highly polymorphic markers available. The number of
alleles ranged from 3 (apo E) to 21 (LDL-R), and het-
erozygosity indices were within the range of .43–.91.
Candidate-gene genotypes were determined for a total
of 126 DZ twin pairs (252 women). However, since both
co-twins are needed for this analysis, pairs were excluded
if a genotype could not be obtained for one or both co-
twins in a pair. Thus, the sample sizes varied slightly for
specific candidate genes.
All PCRs were performed on a Tetrad PTC225 Peltier
Thermal Cycler (MJ Research), by use of Taq polymer-
ase (Gibco-BRL) and the buffer recommended by the
manufacturer, with 8 pmol of each PCR primer. Geno-
typing of the apo E gene, to identify the three alleles E2,
E3, and E4, was determined by use of the method de-
scribed in the study by Bolla et al. (1995). The apo B
VNTR in the 3′ UTR was genotyped in accordance with
the method described in the study by Boerwinkle et al.
(1989). All other genotyping was performed by use of
fluorescent-labeled forward primers (Applied Biosystems
[synthesized by Oswell; nonfluorescent reverse primers
were synthesized by Gibco-BRL]). Allele sizing was per-
formed on a 373 or a 377 automated sequencer (Applied
Biosystems).
The CA repeat in intron 10 of the MTP gene was
amplified by use of the following oligonucleotides: for-
ward, TAMRA (N,N,N′N′-tetramethyl-6 carboxyrho-
damine)-5′-TCC ACA AGG ATT CAT AAC C-3′, and
reverse, 5′-TTC TCC ACT CTT CCC CAT-3′ (R. Gregg,
personal communication ); and the following PCR-am-
plification conditions were used: one cycle of 95C for
4 min and then 30 cycles of 95C for 1 min, 55C for
1 min, and 72C for 1 min, followed by a final extension
at 72C for 5 min. The tetranucleotide repeat in intron
20 of the apo B gene was genotyped with a FAM (6-
carboxyflourescein)–labeled forward oligonucleotide, by
use of oligonucleotide sequences described in the study
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by Zuliani and Hobbs (1990a). Apo CIII amplification
of intron 3 (Zuliani and Hobbs 1990b) was performed
with the following oligonucleotides: forward, FAM-5′-
GCA GAG ATG ACA GAG TTG AG-3′, and reverse,
5′-GGT TGC AGT GAG CCG AGA TG-3′; and the fol-
lowing PCR conditions were used: one cycle of 95C for
4 min and then 30 cycles of 95C for 1 min and 72C
for 3 min. Five pairs of MZ twins were genotyped for
this marker, and the co-twins of all five pairs had iden-
tical genotypes.
The PCR for dinucleotide-repeat sizing of the HL,
HSL, and IR genes was multiplexed in a single reaction
tube, by use of the following PCR conditions: one cycle
of 95C for 4 min and then 30 cycles of 95C for 1 min,
55C for 30 s, and 72C for 2.5 min. Oligonucleotide
sequences were as reported elsewhere (for HL, Bhatta-
charya et al. 1991; for HSL, Levitt et al. 1992; and for
IR, Xiang et al. 1991). To distinguish the sizing of the
three dinucleotide repeats, forward primers were labeled
with the following fluorescent ABI labels: for HL,
TAMRA; for HSL, FAM; and for IR, TET (4,7,2′,7′-
tetracholoro-6-carboxyfluorescein). Analysis of the
polymorphic microsatellite D19S394, a marker for the
LDL-R—which is located ∼250 kb telomeric and 5′ to
the LDL-R—was performed as described elsewhere (Day
et al. 1997).
Statistical Genetic Analysis
Quantitative sib-pair linkage analysis, using the SIB-
PAL program from the SAGE (1994) package, was used
to test for genetic linkage between the lipoprotein phe-
notypes and the candidate genes. In this regression ap-
proach, quantitative variation in the lipoprotein phe-
notype, between co-twins, is examined as a function of
shared alleles of the polymorphic marker of the candi-
date gene. A regression line is then calculated, with the
squared difference (squaring is used to obtain only pos-
itive values) in the lipoprotein phenotypes of co-twins
as the dependent variable and the number of shared
alleles identical by descent (IBD) as the independent var-
iable (Haseman and Elston 1972). If the slope of this
line is negative and is significantly different from zero,
with the appropriate df (Blackwelder and Elston 1982),
the result is interpreted as evidence for linkage between
the lipoprotein phenotype and the candidate gene. For
each lipoprotein phenotype, the slope of the line reflects
the strength of the relationship; hence, it can be inter-
preted as a measure of the magnitude of the evidence
for linkage and can be compared for different candidate
genes (but not for different phenotypes, owing to scale
differences). Thus, both the regression slopes and the
corresponding P values are reported here.
Same-sex twin pairs are ideal for this approach, be-
cause they are matched for age and gender, the two most
important confounding variables in the evaluation of
lipoprotein phenotypes, especially LDL size (Austin et
al. 1990a, 1990b). Thus, no statistical adjustments for
these variables were needed. The analysis first focused
on LDL size and plasma TG levels. Because sib-pair anal-
ysis is sensitive to outliers that may lead to false-positive
findings, three pairs in which one co-twin had a TG value
1400mg/dl were excluded from the analysis. In addition,
since the TG distribution was skewed, a natural log (ln)
transformation was applied to plasma-TG values, to bet-
ter approximate a Gaussian distribution.
When potential linkage was found for LDL size and/
or for TG, by use of an a level of .05, possible linkage
to other lipoprotein variables associated with the two
phenotypes—including HDL cholesterol, apo B plasma
levels, and LDL cholesterol—was then evaluated, to
minimize type II error. This approach was used to insure
that each potential linkage was detected. However, it is
important to note that, owing to the multiple compar-
isons performed and to the finite nature of the genome,
type I error could have led to false-positive results, in
this setting.
Since parental data were not available in this twin
study, observed allele sharing between co-twins repre-
sents identity by state (IBS) rather than IBD. However,
IBD can be estimated from IBS, by use of the frequencies
of alleles for each marker, resulting in IBD values that
differ from 2, 1, and 0. This estimation procedure is
implemented in the SIBPAL program, which applies an
algorithm described in the study by Amos (1988, pp.
56–58), and was used in this analysis. Ideally, popula-
tion-based allele frequencies are used for this purpose.
However, for several of the markers used in this study,
such data are not currently available. Therefore, allele
frequencies estimated from the same sample of DZ twins
were used. Allele frequencies for the entire sample were
used, because they were similar to frequencies based on
one randomly selected co-twin/pair. In addition, the lack
of parental data precluded construction of definitive
haplotypes for the two apo B markers examined.
In order to evaluate IBS data directly, without having
to estimate IBD sharing, twin pairs also were stratified
into those sharing 2, 1, or 0 alleles IBS, when evidence
for linkage was found for a specific marker. Co-twin
intraclass correlations of appropriate phenotypes,within
these groups, were then calculated by use of the FCORR
program, also in the SAGE (1994) package. When link-
age is present, twin pairs sharing 2 alleles IBS are ex-
pected to have higher correlations than those sharing 1
allele, which, in turn, should be higher than those of
pairs sharing 0 alleles. Since the standard errors of in-
traclass correlations are difficult to compute, P values
based on interclass correlations of the same sample sizes
are reported.
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Table 2
Slopes and P Values from the Quantitative Sib-Pair Linkage
Analysis Based on DZ Women Twins, for LDL-PPD and TG Level
CANDIDATE-
GENE
MARKER
NO. OF
PAIRS
REGRESSION SLOPE (P VALUE)
LDL-PPD ln of TG Level
MTP 120 7.83 (.402) .32 (.031)
HL 122 36.28 (.863) .14 (.222)
HSL 124 13.58 (.318) .16 (.153)
Apo B 119 75.71 (.014) .34 (.017)
Apo CIII 119 33.24 (.893) .11 (.235)
Apo E 117 32.79 (.761) .06 (.413)
IR 123 26.27 (.258) .19 (.841)
LDL-R 121 34.52 (.082) .20 (.071)
Figure 1 Results of quantitative sib-pair linkage analysis of the MTP gene in DZ women twins. The X-axis indicates the estimated number
of alleles shared by co-twins in a pair, at the MTP marker (see table 1). The Y-axis indicates the squared co-twin difference in TG level (in mg/
dl). Note the significant negative slope ( ) of the regression line, which is consistent with evidence for genetic linkage.P  .031
Results
Quantitative Sib-Pair Linkage Analysis of LDL-PPD and
TG
The results of the sib-pair linkage analysis for LDL-
PPD and TG are summarized in table 2. Evidence for
linkage is seen between the MTP gene and TG, at the
0.05 level, but not for MTP and LDL-PPD. As shown
in figure 1, the plot of the estimated proportion of alleles
IBD at the MTP locus versus the co-twin difference in
the squared ln TG level, the regression line has a sig-
nificantly negative slope (0.32, ), which isP  .031
consistent with genetic linkage between the MTP gene
and variation in plasma TG levels.
No evidence for linkage with either LDL-PPD or TG
was obtained for the HL gene, the HSL gene, the apo
AI-CIII-AIV gene complex, the apo E gene, or the IR
gene (table 2). However, the analysis showed evidence
for linkage of the apo B gene to both LDL-PPD and TG
( and , respectively; table 2). FigureP  .014 P  .017
2A and B shows the regression lines (with slopes of
75.71 and 0.34, respectively) from the sib-pair anal-
yses of the apo B gene, for LDL-PPD and the ln of the
squared TG level. The significant negative slopes are
clearly shown in both plots, indicating that those pairs
who are more alike at the apo B locus have more similar
values for LDL size and TG. Finally, borderline statis-
tically significant results for linkage between the LDL-
R gene and both of these phenotypes were found (P 
and , respectively; table 2)..08 P  .07
Co-Twin Intraclass Correlations
Each of the significant findings (using ) de-P ! .05
scribed above was examined further by comparison of
intraclass correlations among twin pairs sharing 2, 1, or
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Figure 2 Results of quantitative sib-pair linkage analysis of the apo B gene in DZ women twins. The X-axis indicates the estimated
number of alleles shared by co-twins in a pair, at the apo B VNTR marker (see table 1). The Y-axis indicates the squared co-twin difference
in (A) LDL-PPD (in A˚) and (B) TG level (in mg/dl). A significant negative slope (75.71, , and 0.34, , respectively) is seenP  .014 P  .017
for the regression line in each plot, which is consistent with evidence for genetic linkage.
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Table 3
Co-Twin Correlations for DZ Women Twins Sharing 2, 1, or 0
Alleles IBS
Marker and
No. of Alleles
Shared No. of Pairs
ln of TG Level
(mg/dl)
LDL-PPD
(A˚)
MTP:
2 52 .624∗ )
1 59 .334∗∗ )
0 9 .071 )
Apo B VNTR:
2 46 .687∗ .630∗
1 62 .454∗ .550∗
0 12 .379 .255
∗ .P ! .001
∗∗ .P ! .01
Table 4
Slopes and P Values from the Quantitative Sib-Pair Linkage Analysis Based
on DZ Women Twins, for HDL Cholesterol, Apo B Plasma Levels, and LDL
Cholesterol
CANDIDATE-
GENE
MARKER
REGRESSION SLOPE (P VALUE)
HDL Cholesterol Apo B Level LDL Cholesterol
MTP 390.64 (.926) 396.69 (.121) 646.14 (.202)
Apo B VNTR 322.82 (.113) 656.95 (.007) 669.36 (.199)
0 alleles IBS, thus avoiding estimation of IBD status.
(Note that the expected .25, .50, and .25 Mendelian
frequencies of pairs sharing 2, 1, or 0 alleles IBD were
not observed, since IBS was used for stratification
[Thomson and Motro 1994]). For MTP and TG, intra-
class correlations of .62, .33, and .10 were found among
those co-twins sharing 2, 1, or 0 alleles IBS, respectively
(table 3). This dose-response relationship of correlations
shows that TG values were more similar among co-twins
who are genotypically more similar at the MTP locus,
possibly reflecting a gene dosage effect.
Twin pairs were also divided into those sharing 2, 1,
or 0 alleles IBS at the apo B VNTR-marker locus, and
intraclass co-twin correlations were calculated for LDL-
PPD and TG. As shown in table 3 and figure 3, signif-
icant intraclass correlations of LDL size were seen
among pairs sharing 2 alleles or 1 allele at the apo B
locus but not among those sharing 0 alleles. The similar
magnitude of the correlations among twins sharing 2
alleles and those sharing 1 allele could indicate that an
apo B allele is having a dominant or a codominant effect
on LDL size. Intraclass correlations for TG were highest
among pairs sharing 2 alleles at the apo B gene, de-
creased among those sharing 1 allele, and were not sta-
tistically significant for those sharing 0 alleles.
Quantitative Sib-Pair Linkage Analysis of HDL
Cholesterol, Apo B Level, and LDL Cholesterol
For each of the candidate genes showing linkage to
LDL-PPD and/or to TG, sib-pair linkage analysis was
also performed for other lipoproteins related to the ath-
erogenic lipoprotein phenotype (table 4). For MTP, this
analysis provided no evidence for linkage of this gene
to HDL cholesterol, apo B plasma levels, or LDL cho-
lesterol. Thus, this result appears to be specific for pos-
sible linkage between theMTP gene and TG. In contrast,
evidence for linkage of the apo B gene to apo B plasma
levels was seen ( ), but no evidence of linkageP  .007
was seen for HDL or LDL cholesterol.
Sib-Pair Linkage Analysis among LDL Subclass
Phenotype A Twin Pairs
Unlike previous studies of LDL size and the apo B
gene (Austin et al. 1991; LaBelle et al. 1991), the fre-
quency of LDL subclass phenotype B was only 11%
among the women in this study (Selby et al. 1993), com-
pared with 25%–30% in other studies (Austin et al.
1990a). Thus, we hypothesized that the observed linkage
may be attributable to LDL size in the intermediate-to-
large range. To address this question, we repeated the
sib-pair linkage analysis, including only all pairs in
which both co-twins had LDL size 1255 A˚, a group with
a high prevalence of LDL subclass phenotype A. As
shown in table 5, the P value for MTP and TG linkage
increased to .099, and the slope for this subsample de-
creased, indicating that the subjects with LDL particle
size !255 A˚ contributed to the evidence for linkage of
this gene to TG.
For the apo B gene VNTR marker, P values remained
!.05 for linkage with LDL-PPD, TG, and apo B plasma
levels, in this subset. To explore this linkage further,
genotyping at another apo B marker, located in intron
20 of the apo B gene, was performed (see table 1). Al-
though this marker had fewer alleles, decreasing the sta-
tistical power to detect linkage, a similar pattern of re-
sults was again seen. In particular, the slopes for
LDL-PPD and the two apo B markers were very similar
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Figure 3 Similarity of co-twin values for phenotypes of LDL-PPD (in A˚), among pairs sharing (A) 2, (B) 1, or (C) 0 alleles IBS at the
apo B VNTR marker. Samples sizes were 46, 61, and 12 twin pairs, respectively, and intraclass co-twin correlations are shown. The X-axis
indicates the value for one randomly selected co-twin/pair, and the Y-axis indicates the value for the other co-twin of the same pair.
(43 and41, respectively), although these values were
less than the slope for the VNTR marker in the full
sample (76; table 2). Since the range of LDL-PPD was
more limited in the subset of women with LDL-PPD
1255 A˚, the standard error of the slopes was reduced.
Thus, the slopes for the subset remain statistically sig-
nificant, despite the decrease in absolute value.
Interestingly, a more negative slope and a lower P
value for linkage to HDL cholesterol were seen for the
apo B intron 20 marker than were seen for the apo B
VNTR marker (slope of 635 and vs. slopeP  .032
of353 and , respectively), suggesting that thisP  .113
phenotype also may be influenced by the apo B locus,
among the subset of women with LDL-PPD 1255 A˚.
This notion is further supported by HDL cholesterol co-
twin correlations of .39 ( ), .24 ( ), andP ! .01 P ! .05
.19 ( ), for pairs sharing 2, 1, or 0 apo B intronP 1 .50
20 alleles, respectively.
Discussion
Taken together, these results provide preliminary ev-
idence that the apo B gene is genetically linked to the
LDL-PPD, TG, HDL cholesterol, and apo B plasma lev-
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Table 5
Slopes and P Values from the Quantitative Sib-Pair Linkage Analysis Based on DZ Women Twin Pairs with LDL
Subclass Phenotype A (LDL-PPD 1255 A˚), for Both Co-Twins
CANDIDATE-
GENE
MARKER
NO.
OF
PAIRS
REGRESSION SLOPE (P VALUE)
LDL-PPD ln of TG Level HDL Cholesterol Apo B Level LDL Cholesterol
MTP 102 2.49 (.451) .16 (.099) 417.57 (.934) 312.53 (.055) 662.71 (.143)
Apo B:
VNTR 103 43.25 (.011) .28 (.005) 352.82 (.113) 325.23 (.045) 575.57 (.178)
Intron 20 103 40.83 (.048) .16 (.148) 635.03 (.032) 320.51 (.094) 1,070.48 (.085)
Table 6
Candidate-Gene Linkage Studies of LDL Subclass Phenotypes and LDL Size
CANDIDATE
GENE CHROMOSOME
LOD
SCORE(S)
FOR FAMI-
LIES, AT
v  .001
P VALUE FROM SIB-PAIR ANALYSISa
CAD Familiesb DZ Women Twinsc
MTP 4q ) ) NS
HL 15q ) ) NS
HSL 19q ) ) NS
Lipoprotein
lipase 8p ) NS )
CETP 16q ) .03 )
MnSOD 6q ) .001 )
Apo B 2p 7.5,d 6.1e NS .014
Apo AI-CIII-AIV
complex 11q ) .06 .893
Apo AII 1p ) NS )
Apo E 19q ) NS NS
IR 19p 1.4f ) NS
LDL-R 19p 4.4f .01 .082
a NS  not significant. An ellipsis ()) indicates that the data were not reported.
b From the study by Rotter et al. (1996).
c From this study.
d From the study by LaBelle et al. (1991).
e From the study by Austin et al. (1991).
f From the study by Nishina et al. (1992).
els, all components of an atherogenic lipoprotein
phenotype, in this sample of adult women twins. Fur-
thermore, these relationships appear to be present
among women with LDL in the intermediate-to-large
size range, as well as in the entire sample of twins. This
implies that the apo B gene contributes to variation of
LDL size in the intermediate-to-large size range.
This implication is not inconsistent with two previous
studies that had provided definitive evidence against
linkage of the apo B gene and LDL subclass phenotype
B (by use of the same VNTR marker) in primarily
healthy families (LaBelle et al. 1991) and in families with
FCHL (Austin et al. 1991) (table 6). That is, both of
these previous studies used a dichotomous definition of
larger and smaller LDL subclass phenotypes, whereas
the current study used LDL-PPD as a continuous vari-
able and found evidence for linkage even when the anal-
ysis was limited to the intermediate-to-large size range.
Furthermore, these analyses were based on a LOD-score
linkage analysis of families that assumes a specific model
of single-gene inheritance, rather than on the nonpara-
metric sib-pair approach reported here. However, a re-
cent study of sib pairs from families with CAD also
found no evidence for linkage of LDL-PPD to the apo
B gene, over the full range of LDL size (Rotter et al.
1996). It is also important to note that, unlike previous
studies, the current analysis is based entirely on women.
Because of the strong evidence for major-gene effects
on LDL heterogeneity, obtained from complex segre-
gation analysis, several studies have investigated other
candidate genes for linkage to LDL size (table 6). The
study noted above (Rotter et al. 1996), based on sib
pairs from CAD families, showed no linkage to the LPL
gene but did find evidence for linkage to the CETP gene
and the MnSOD gene, although these findings remain
to be confirmed by other studies. In that study, border-
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line statistically significant evidence for linkage to the
apo AI-CIII-AIV gene complex also was found, whereas
no such evidence emerged from the present study. To
date, there is no evidence for linkage to either the apo
AII gene or the apo E gene, despite the recent report of
an association between LDL size and the apo E isoforms
(Haffner et al. 1996). However, because the apo E poly-
morphism is only triallelic, there was little statistical
power to detect linkage, in the present analysis. Of the
two studies investigating the IR, neither have found ev-
idence for linkage.
For linkage between the LDL-R gene and both LDL-
PPD and TG, the quantitative sib-pair analysis in this
study demonstrated borderline statistically significant re-
sults, similar to previous findings of linkage between the
LDL-R and (a) LDL subclass phenotype B in families
(Nishina et al. 1992) and (b) LDL size in sib pairs from
CAD families (Rotter et al. 1996). Furthermore, when
twin pairs were divided into groups of those sharing 2,
1, or 0 alleles IBS for the LDL-R–gene marker, the cor-
relations were .66 ( ), .47 ( ), and .36P ! .001 P ! .001
( ). However, as in the earlier studies, the LDL-RP ! .05
was not linked to the other lipoprotein measures char-
acteristic of the atherogenic lipoprotein phenotype, in-
cluding HDL cholesterol, apo B plasma levels, and LDL
cholesterol (data not shown). Thus, the role of the LDL-
R gene in determination of LDL size remains to be fully
elucidated.
In addition to the results for LDL-PPD, evidence for
linkage between the MTP gene and plasma TG was
found, at the 0.05 level (table 2). Among the entire sam-
ple of women, this result was limited to TG and was
not found to be the case for other lipoprotein measures.
However, when the analysis was specific to women twin
pairs with LDL subclass phenotype A, a borderline sta-
tistically significant linkage between MTP and apo B
plasma levels also was found (slope of 313, P 
). Both of these results are intriguing, since MTP is.055
known to be involved in the assembly of apo
B–containing lipoprotein particles in the liver (Jamil et
al. 1996) and is a cause of abetalipoproteinemia (Narcisi
et al. 1995). If confirmed, these results would imply that
the MTP gene influences TG in most individuals,
whereas the influence on apo B levels may be limited to
those with relatively large LDL size.
In this sample of women twins, heritability analysis
demonstrated significant genetic influences on plasma
apo B levels. Specifically, the intraclass correlations were
.701 ( ) for MZ twins and .494 ( ) forP ! .001 P ! .001
DZ twins, resulting in a classic heritability estimate of
.413 ( ). This candidate-gene analysis suggestsP ! .001
that both the MTP gene and the apo B gene contribute
to this heritability of apo B levels, at least in women.
In contrast to previous association studies of both an-
imal models and human populations (Ito et al. 1990;
Dammerman et al. 1993; Zeng et al. 1995), no genetic
linkage was observed between the apo CIII gene and TG
levels. Because of the relatively limited sample size in
this study, it is possible that there was not sufficient
statistical power to detect this linkage. Most studies of
apo CIII polymorphisms report associations with severe
hypertriglyceridemia, whereas all the women included
in this study had TG levels !400 mg/dl. Thus, the apo
CIII gene may not have a strong influence on TG in this
range, despite its role in severe elevations of TG.
It is important to note that the sample size in this sib-
pair analysis of 126 pairs is limited, compared with that
in many such studies. Although the use of women twins
eliminates potentially confounding effects owing to age
and sex, the statistical power available may have limited
the ability to detect true genetic linkages. To reduce this
possibility (type I error), an a value of 0.05 has been
used as the criteria for statistical significance, without
adjustment for multiple comparisons or consideration of
the finite nature of the human genome. However, this
approach could have resulted in false-positive results,
emphasizing the necessity for replication of these find-
ings, in other populations.
In summary, these candidate-gene sib-pair analyses of
adult DZ women twins have suggested genetic linkage
between the apo B gene and LDL size, plasma levels of
TG, HDL cholesterol, and apo B, all features of the
atherogenic lipoprotein phenotype. Furthermore, this re-
sult was maintained when the analysis was limited to
women with intermediate-to-large LDL, suggesting that
the apo B gene may influence LDL heterogeneity in the
larger size range. In addition, moderate evidence for link-
age between the MTP gene and plasma TG was found
among all the women. These findings add to the growing
evidence for genetic influences on the features of the
atherogenic lipoprotein phenotype and for its role in
genetic susceptibility to atherosclerosis.
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